Pulmonary Disease: Testing techniques to remove airflow between lung compartments - Wesley Research Institute
Wesley Research Institute
Donate
Now

Research Objectives

Status

Current

Recruitment

Closed

Patient Group

Chronic Obstructive Pulmonary Disease/Severe Emphysema

Study type

Industry Sponsored
Sponsors: Pulmonx Corporation

Lead investigator

  • Dr Farzad Bashirzadeh

Clinical trial coordinators

  • Leah Hingston
  • Chris Henderson

Technical title

Fissure Closure with the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema; A Multicenter, Prospective Trial (CONVERT Trial)

About this research project

Chronic obstructive pulmonary disease (COPD) makes breathing difficult. This can often be improved by implanting a valve (called the Zephyr Valve) into the most diseased part of the lung to improve breathing. Currently, the Zephyr Valve can only be inserted into the lung when there are no open air channels between the compartments where the valve is situated. This means that patients who do have open air channels, cannot currently have this valve inserted to improve breathing.

This study is testing the use of the AeriSeal System to close these channels (we call it “fissure closure”) during a bronchoscopy procedure to see if it is an effective technique to close the air channels between the lungs and remove the air flow between the lung compartments. If the closure of the fissure is successful, your study doctor can then perform the Zephyr Valve Procedure to treat COPD symptoms. This Study is, then, combining both procedures (the AeriSeal System and the Zephyr Valve) to improve breathing function.

Latest News

Jillian’s Story

This was my first experience at being involved in any sort of research. If I get the opportunity again, I would definitely put my hand up after the wonderful experience I had with your team. Thank you so much to Emma and all your team for making me feel so welcome.    Jillian Meet Jillian, retired […]

Breaking Ground in Paediatric Rare Disease Research

Wesley Research Institute is home to a groundbreaking trial using triheptanoin, a dietary fat, to treat Ataxia-Telangiectasia (A-T), a rare degenerative neurological disorder. This trial has shown promising results, with observed improvements in neurology scales and cellular biomarkers indicating the treatment’s effectiveness.

World-First ‘Back to the Future’ Research Set To Boost Pandemic Protection  

A world-first research project by two Queensland professors is set to offer a blueprint for developing more effective vaccines and therapies specifically tailored to safeguard the health of children and young adults in times of global health crises.  Spearheaded by Professor John Fraser, Dr Arutha Kulasinghe and Associate Professor Kirsty Short, this pioneering study, funded […]
1 2 3 12
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram